621 results on '"Uitdehaag, Bernard M. J."'
Search Results
2. Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trial
3. The cognitive relevance of non-lesional damage to cortical networks in people with multiple sclerosis
4. Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial
5. Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis
6. A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort
7. Adipokines in multiple sclerosis patients are related to clinical and radiological measures
8. Don’t be late! Postponing cognitive decline and preventing early unemployment in people with multiple sclerosis: a study protocol
9. Don’t be late! Timely identification of cognitive impairment in people with multiple sclerosis: a study protocol
10. Measuring and predicting the effect of remyelinating therapy in multiple sclerosis: a randomised controlled trial protocol (RESTORE)
11. The association between weight during early life and multiple sclerosis onset in a nationwide Dutch birth year cohort.
12. Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance
13. Longitudinal fibre-specific white matter damage predicts cognitive decline in multiple sclerosis.
14. Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study.
15. The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort
16. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
17. Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis
18. Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumors
19. Autoencoder as a New Method for Maintaining Data Privacy While Analyzing Videos of Patients With Motor Dysfunction: Proof-of-Concept Study
20. Assessment of Multiple Aspects of Upper Extremity Function Independent From Ambulation in Patients With Multiple Sclerosis.
21. Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis
22. Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis
23. Adipokines in multiple sclerosis patients are related to clinical and radiological measures
24. A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage
25. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
26. The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis
27. novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage.
28. Outcome Measures in Clinical Trials for Multiple Sclerosis
29. Joint modeling of longitudinal health-related quality of life data and survival
30. The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis
31. Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands
32. Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis.
33. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study
34. Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a
35. A more unstable resting-state functional network in cognitively declining multiple sclerosis
36. Do neurocognitive impairments explain the differences between brain tumour patients and their proxies when assessing the patient’s IADL?
37. Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study
38. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant
39. Physiological variation of segmented OCT retinal layer thicknesses is short-lasting
40. Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15
41. Reduced accuracy of MRI deep grey matter segmentation in multiple sclerosis : an evaluation of four automated methods against manual reference segmentations in a multi-center cohort
42. A multidisciplinary neuro-oncological triage panel reduces the time to referral and treatment for patients with a brain tumor
43. SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort
44. Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis
45. Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study
46. Health-related Quality of Life in Patients with Brain Tumors: Limitations and Additional Outcome Measures
47. The plantar reflex: additional value of stroking the lateral border of the foot to provoke an upgoing toe sign and the influence of experience
48. Pediatric meningiomas in The Netherlands 1974–2010: a descriptive epidemiological case study
49. Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes
50. A model for interrogating the clinico‐radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.